2011
DOI: 10.1016/j.juro.2011.02.415
|View full text |Cite
|
Sign up to set email alerts
|

332 Finasteride for Recurrent Priapism in Children and Adolescents With Sickle Cell Disease (Scd). Report of 5 Cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In the case of this patient, though leuprolide was very well tolerated for an extended period of time, the choice was eventually made to transition to finasteride due to concerns about long term effects of hormonal manipulation. Finasteride, a 5α-reductase inhibitor, has been described as an effective prophylactic therapy for recurrent priapism, though the mechanism by which it acts in this context is unclear 5 . At the time of this report, the patient's priapism remains suppressed after several months of finasteride therapy in spite of discontinuation of leuprolide.…”
Section: Discussionmentioning
confidence: 99%
“…In the case of this patient, though leuprolide was very well tolerated for an extended period of time, the choice was eventually made to transition to finasteride due to concerns about long term effects of hormonal manipulation. Finasteride, a 5α-reductase inhibitor, has been described as an effective prophylactic therapy for recurrent priapism, though the mechanism by which it acts in this context is unclear 5 . At the time of this report, the patient's priapism remains suppressed after several months of finasteride therapy in spite of discontinuation of leuprolide.…”
Section: Discussionmentioning
confidence: 99%